Healthcare -
Biotechnology - NASDAQ - US
$ 32.3
-1.02 %
$ 3.86 B
Market Cap
-6.06
P/E
CYTK - STOCK-BASED COMPENSATION
Stock-based Compensation CYTK - Cytokinetics, Incorporated
97.8 M
LAST VALUE
42.99%
2 YEAR CAGR
55.51%
5 YEAR CAGR
40.22%
10 YEAR CAGR